The Department of Health and Human Services Food and Drug Administration awarded an indefinite delivery, indefinite quantity contract to Koniag Management Solutions LLC with a potential value of $25,000,000. Task orders issued against the contract procure scientific support services including research, laboratory analysis, and subject matter expertise to support the FDA's regulatory, compliance and public health programs. Task orders awarded to Koniag Management Solutions LLC and described in...
The Department of Health and Human Services Food and Drug Administration awarded an Indefinite Delivery Contract with a potential value of $25 million to Midnight Sun Technologies LLC. The contract is a single award, 8(a) sole source set aside for scientific support services to be performed across multiple locations including Silver Spring, MD, Vienna, VA, and Calverton, MD. The contract aims to procure subject matter expertise through various labor categories such as Scientist III, Researcher...
The Department of Health and Human Services (HHS) Food and Drug Administration (FDA) awarded an Indefinite Delivery Contract (IDC) to Research Triangle Institute (RTI International), a non-profit research organization, for the "Economic Studies of FDA Regulations" program. The $9,901,000 multiple-award IDC has a period of performance through September 14, 2024. Under this IDC, RTI has been issued several delivery orders, including: A $0 task order to develop an economic...
The Department of Health and Human Services Food and Drug Administration awarded an indefinite delivery contract to the National Academy of Sciences with a potential value of $30,000,000.00. The contract establishes a forum for the agency to convene committees for assessment, evaluations, and studies related to public health issues. Five task orders have been awarded against the contract to date, with periods of performance ranging from September 2022 through September 2025. Task orders...
The Indefinite Delivery Contract 75F40118D10113 was awarded by the Food and Drug Administration (FDA), a civilian federal agency, to the prime contractor Research Triangle Institute (RTI International), a non-profit research organization. The contract, which has a ceiling value of $331,175.33 and a period of performance through December 30, 2022, is for a formative research study to understand the impact of generic drug-device substitutes on various patient and caregiver populations. RTI...
The U.S. Food and Drug Administration (FDA), a civilian agency within the Department of Health and Human Services, awarded a $30 million single-award Indefinite Delivery Indefinite Quantity (IDIQ) contract to Spaulding Clinical Research, LLC, a self-certified small disadvantaged business, for-profit organization, and limited liability company. The IDIQ contract, awarded in 2019 with a last ordering date of September 2024, enables the FDA to issue task orders to Spaulding for clinical and...
The Department of Health and Human Services Food and Drug Administration awarded an indefinite delivery contract to We Pharma, Inc., doing business as WEP Clinical, with a potential value of $9.5 million. The contract has no set-aside designation and is a single-award arrangement to provide currently marketed drug products for FDA research studies from September 2020 through September 2025. Under this contract, WEP Clinical has received multiple firm fixed price delivery orders to supply...
The Department of Health and Human Services Food and Drug Administration awarded an indefinite delivery contract to Goldbelt C6, LLC with a potential value of $20 million. Goldbelt C6, LLC is a subsidiary of Goldbelt, Incorporated and was awarded this contract as a single-award IDV to provide various research, analytical, and scientific support services to the agency through September 2028. Under this IDV, Goldbelt C6 has received multiple delivery orders from HHS FDA totaling over $30 million...
The Department of Health and Human Services Food and Drug Administration awarded a single award indefinite delivery contract to Lovelace Biomedical Research Institute with a potential value of $25 million. To date, two firm fixed price delivery orders have been awarded against the contract. Task Order 1, valued at $3.8 million, tasks Lovelace Biomedical Research Institute to determine if reductions in biomarkers of exposure and potential harm are proportional to reductions in cigarette smoking...
The Department of Health and Human Services Food and Drug Administration awarded a single award indefinite delivery contract to Core Human Factors, Inc. with a potential value of $10,000,000. The contract aims to procure comparative use human factors studies to assess the impact of differences between the user interfaces of generic drug-device combination products and their reference listed drugs. A firm fixed price delivery order for $1,035,113 was issued against this contract. Core Human...